Dibenzo [a, c] phenazin-11-yl(phenyl) methanone (SBLJ23), a novel selective inhibitor targeting JAK2(V617F) mutation in myeloproliferative neoplasms.

二苯并[a, c]吩嗪-11-基(苯基)甲酮 (SBLJ23) 是一种新型选择性抑制剂，靶向骨髓增生性肿瘤中的 JAK2(V617F) 突变